Skip to content
GeneInCell cover art

Vinod Reddy Lekkala

GeneInCell

A Life Sciences and Science podcast

Good podcast? Give it some love!

About the show

GeneInCell-The AI-powered Biotech Podcast focuses on crisp, science-based podcasts on stem cells, organoids, and gene editing—tracking breakthroughs from bench to bedside for better human health, including Biotech and business.

Newest episodes

Optogenetics Wins the 2026 Nobel Prize- Controlling the Brain with Light | GeneInCell | 2026

50 min

Optogenetics has transformed neuroscience by letting scientists control specific nerve cells with light. In this episode, we explore the discoveries behind the 2026 Nobel Prize in Physiology or Medicine, how light-sensitive ion channels became powerful tools for mapping brain circuits, and how optogenetics is opening new possibilities for understanding—and potentially treating neurological and sensory disorders.

AlphaGenome: Finding Disease in the Dark Genome | GeneInCell | 2026

44 min

AlphaGenome Atlas is helping decode the 98% of the human genome that doesn’t code for proteins. By predicting how non-coding variants affect transcription, splicing, chromatin accessibility, and gene regulation, it can prioritize potentially harmful mutations, clarify rare disease cases, and reveal regulatory mechanisms hidden in the “dark genome.”

Can mRNA Vaccines Fight Cancer? | GeneInCell | 2026

54 min

Can mRNA vaccines train the immune system to recognize and attack cancer? In this episode, we explore how mRNA cancer vaccines are designed, how they deliver tumor-specific instructions to immune cells, and why personalized neoantigen vaccines are gaining attention. We also cover current clinical progress, the potential to combine mRNA vaccines with immunotherapy, and the challenges that remain to be solved before these approaches become routine cancer treatments.

Similar podcasts

All episodes

Optogenetics Wins the 2026 Nobel Prize- Controlling the Brain with Light | GeneInCell | 2026

50 min

Optogenetics has transformed neuroscience by letting scientists control specific nerve cells with light. In this episode, we explore the discoveries behind the 2026 Nobel Prize in Physiology or Medicine, how light-sensitive ion channels became powerful tools for mapping brain circuits, and how optogenetics is opening new possibilities for understanding—and potentially treating neurological and sensory disorders.

AlphaGenome: Finding Disease in the Dark Genome | GeneInCell | 2026

44 min

AlphaGenome Atlas is helping decode the 98% of the human genome that doesn’t code for proteins. By predicting how non-coding variants affect transcription, splicing, chromatin accessibility, and gene regulation, it can prioritize potentially harmful mutations, clarify rare disease cases, and reveal regulatory mechanisms hidden in the “dark genome.”

Can mRNA Vaccines Fight Cancer? | GeneInCell | 2026

54 min

Can mRNA vaccines train the immune system to recognize and attack cancer? In this episode, we explore how mRNA cancer vaccines are designed, how they deliver tumor-specific instructions to immune cells, and why personalized neoantigen vaccines are gaining attention. We also cover current clinical progress, the potential to combine mRNA vaccines with immunotherapy, and the challenges that remain to be solved before these approaches become routine cancer treatments.

Anti-Aging Peptides- Can We Slow the Biology of Aging? | GeneInCell | 2026

1 hr 3 min

Can peptides help slow the biological processes of aging? In this episode, we explore how anti-aging peptides may influence cellular repair, inflammation, metabolism, collagen production, and tissue regeneration. We examine the scientific evidence, emerging therapeutic applications, and the limitations and safety concerns surrounding peptide-based approaches to healthier aging.

The Cellular Clock: Telomerase and the Science of Slowing Aging | Longevity | GeneInCell

1 hr 2 min

Telomerase helps protect the ends of chromosomes, but its role in aging is complex. In this episode, we explore how telomeres influence cellular lifespan, whether activating telomerase could slow age-related decline, and the scientific and safety challenges that stand between promising research and future anti-aging therapies.

Can Epigenetic Reprogramming Reverse Aging? | GeneInCell | 2026

57 min

Epigenetic reprogramming is emerging as one of the most intriguing ideas in aging research—the possibility that aging is not just damage, but also a reversible loss of cellular identity. In this episode, we explore how scientists are trying to reset the epigenetic instructions that control gene expression, tissue function, and biological age. We break down the science behind partial reprogramming, what preclinical studies suggest about rejuvenation, regeneration, and lifespan-related outcomes, and why safety, durability, and cancer risk remain major challenges. Can aging really be reversed, or are we only beginning to understand the code that drives it?

Chemical Antibodies: How Aptamers Could Transform Future Therapies | GeneInCell | 2026

57 min

Aptamers are emerging as powerful “chemical antibodies” that can bind targets with high precision while offering advantages in design, synthesis, and stability. In this episode, we explore how these short nucleic acid ligands are selected, how they work, and why they are gaining attention as next-generation tools for diagnostics, targeted delivery, and therapy. We also discuss their potential to reshape future medicine, along with the key challenges that must be solved for broader clinical use.

Antisense Oligonucleotides: Programming RNA to Silence Disease | GeneInCell | 2026

57 min

Antisense oligonucleotides are redefining medicine by programming RNA to silence disease at its source. In this episode, we explore how these short, sequence-designed molecules bind target RNA to reduce harmful protein production, reshape splicing, and open new possibilities for precision therapeutics. We cover the history, mechanism, chemistry, and growing clinical relevance of ASOs, along with their promise and limitations in treating genetic, neurological, retinal, muscular, liver, and rare diseases.

Silencing Genetic Disease with shRNA | GeneInCell | 2026

1 hr 3 min

shRNA is a gene-silencing tool that uses the cell’s own RNA interference machinery to reduce harmful protein production. In this episode, we explore how short hairpin RNAs are designed to target specific mutant genes, how they are delivered into cells, and why they hold promise for treating genetic disease through long-lasting gene knockdown.

Base Editing- Rewriting DNA One Letter at a Time | GeneInCell | 2026

55 min

Base editing is changing the future of gene editing by allowing scientists to rewrite DNA one letter at a time. In this episode, we explore how base editors work, why they offer a more precise alternative to traditional CRISPR cutting, and how they are being used to correct disease-causing mutations. We also look at their growing potential in research and medicine, along with the challenges that remain for safe and effective clinical use.

siRNAs: Programmable Drugs for Silencing Genetic Disease | GeneInCell

1 hr 5 min

siRNAs are transforming medicine by acting as programmable drugs that selectively silence disease-causing genes. In this episode, we explore how small interfering RNAs work through the RNA interference pathway, why they are so powerful for precision therapeutics, and how they are being developed to treat genetic, metabolic, liver, and rare diseases. We also discuss delivery challenges, clinical progress, and what makes siRNA one of the most promising platforms in modern drug development.

Prime editing: Search and replace for human DNA | GeneInCell | 2026

58 min

Prime editing is a next-generation gene editing tool designed to precisely rewrite DNA—like a search-and-replace function for the human genome. In this episode, we break down how prime editing works, the chemistry behind it, and why it offers a powerful alternative to traditional CRISPR by making targeted changes without creating double-strand breaks. We also explore its applications in disease correction, its growing path toward the clinic, and the key challenges that still stand in the way.

Growing replacement kidneys from stem cells | GeneInCell | 2026

51 min

Can we grow new kidneys from stem cells? In this episode, we explore how scientists are using pluripotent stem cells to create kidney organoids that mimic early kidney development. We discuss how these mini-organs help study kidney disease, test new drugs, and move us closer to future regenerative therapies for kidney failure.

Is Space Travel Safe For You? | GeneInCell | 2026

48 min

What really happens to your cells under stress, in space, and during space travel? In this episode, we zoom in on the physiological, cellular, and molecular levels to uncover how zero gravity affects them.

Growing Beating Human Hearts in a Dish | Heart Organoids | GeneInCell

16 min

What does it take to grow a beating human heart in the lab? This episode explores cardiac organoids—self-organizing heart tissues derived from human stem cells that contract, respond to drugs, and model human heart disease. We unpack how iPSCs are guided into cardiac lineages, how electrical and mechanical cues drive maturation, and why these beating mini-hearts are transforming drug safety testing, disease modeling, and the future of regenerative cardiology.

The AI Revolution in Healthcare: 2026 Innovation and Trends | GeneInCell | 2026

35 min

In this episode, we explore the AI revolution in healthcare and what 2026 could look like—from smarter diagnostics and personalized treatments to automation that reshapes clinical workflows. We break down the key innovations, emerging trends, and real-world impact of AI on patients, clinicians, and the healthcare system.

Engineering the Next Wave of Innovation with Synthetic Biology | GeneInCell | 2026

33 min

Synthetic biology is turning cells into programmable factories, sensors, and therapies. In this episode, we explore how DNA can be engineered like code to build smarter medicines, sustainable biomaterials, and living devices—and what it will take to move these innovations from the lab to the real world.

Engineering Blood Vessels for Human Mini Brains | Vascularized Human Brain Organoids | GeneInCell | 2026

36 min

How do you give “mini-brains” a bloodstream? This episode explores vascular brain organoids—cerebral organoids engineered with endothelial cells, pericytes, and astrocytes to form BBB-like barriers, improve oxygen/nutrient delivery, and accelerate neuronal maturation. We cover why perfusion matters for MEA activity and drug testing, how microvessels enable neurovascular-coupling studies, and what it will take to scale these tissues for translational neuroscience.

Growing Biological Computers-Brain Organoids From Human Cells | GeneInCell

26 min

Brain organoids are self-organizing “mini-brains” grown from human stem cells that recapitulate key aspects of early neural development. They fire neural networks on MEAs, model neurodevelopmental and neurodegenerative diseases, and offer human-relevant platforms for drug discovery, circuit mapping, and studying brain evolution—while raising important questions about maturity, reproducibility, and ethics.

Building the Human Gut in a Dish From Pluripotent Stem Cells | GeneInCell | 2026

40 min

Grow a “mini-gut” from stem cells—fast. This episode maps the journey from pluripotent cells to functional intestinal organoids, covering key signals (Activin A, Wnt3a/R-spondin, EGF), culture formats (3D domes vs. monolayers), and core readouts (TEER, permeability, metabolism). We highlight use cases in disease modeling and drug testing.

Intestinal 3D Organ Models: Organoids for Drug Testing

30 min

Discover how 3D intestinal organoids—mini-gut tissues grown from stem cells—are transforming preclinical drug testing. We break down how these models capture human barrier function, absorption, metabolism, and host–microbiome interactions better than animal systems, enabling smarter toxicity profiling and efficacy screening. From patient-derived organoids for precision medicine to organoid-on-chip platforms, we cover practical workflows, readouts (TEER, imaging, omics), and what it takes to translate in-vitro hits into clinical candidates.

DNA Is Binary Code and Logic | GeneInCell | 2025

14 min

DNA as code, cells as computers. We explore how binary models of genomes reveal mutational logic, why evolution mirrors open-source development, and how this lens powers DNA data storage, biomolecular logic gates, and smarter synthetic biology.

DNA Storage: Encoding Digital Data in Nature's Code | GeneInCell

34 min

Silicon is hitting its limits—and our data keeps exploding. In this episode, we explore DNA as a radical new archive: a medium with hyper-dense capacity and millennia-scale stability that doesn’t need power to preserve information. We unpack the workflow—encoding 1s and 0s into A, T, C, and G; writing short DNA oligos; and reading them back with sequencing plus robust error-correction.

CRISPR–Cas9 Variants for High-Fidelity Genome Editing

41 min

Explore the shift from standard Cas9 nuclease—which makes double-strand breaks—to precision tools like Cas9 nickases (single-strand “nicks”) and dead Cas9 (binding without cutting). We break down how these variants reduce off-target indels and enable safer editing and gene regulation (CRISPRi/a, base/prime editor scaffolds) for high-fidelity genome engineering.

Human Liver Organoids- From Stem Cells to Therapies

14 min

From stem cells to therapies, this episode dives into the world of human liver organoids—how iPSCs are guided into functional “mini-livers,” the bioengineering tricks that mature them, and the breakthroughs they enable in disease modeling, drug screening, and precision hepatology. In this short episode, we unpack what’s real, what’s next, and how organoids are accelerating the path to regenerative treatments.

Eyes In a Dish | Modeling Retinal Development with Pluripotent Stem Cells

17 min

How lab-grown mini-retinas model human vision. In this episode, we show how iPSC-derived retinal organoids form layered photoreceptors, enable gene-editing tests (CRISPR, ASOs), and accelerate drug screening for inherited retinal diseases. Clear takeaways, visuals, and translational notes for bench and clinic. Educational only; not medical advice.

Nobel Winning Breakthrough: Unpacking Peripheral Immune Tolerance | GeneInCell

15 min

How FOXP3-defined Tregs prevent autoimmunity and shape therapy. We trace the discoveries by Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi, unpack Treg biology and assays, and explore translational angles—from autoimmune disease and transplantation to cancer immunotherapy and engineered Tregs. Educational content only; not medical advice.

🧬 CRISPR dCas9 Activation Systems for Gene Regulation | GeneInCell | 2025

17 min

How do you turn genes on with CRISPR—without making a single cut? This episode breaks down dCas9-based activators (VP64, p300, SAM, VPR, SunTag), guide design near promoters/enhancers. We compare strengths, limits, and off-target risks. Clear takeaways on assays (qPCR, RNA-seq, ATAC-seq, reporter readouts), durability, and safety considerations for translational work. Educational only; not medical advice.

Antisense Oligonucleotides: From Sequence to Therapy

25 min

Dive into the fascinating world of antisense oligonucleotides (ASOs) with this insightful podcast series. Explore the journey from genetic sequencing to groundbreaking therapeutic applications, uncovering how these innovative molecules are transforming the treatment of genetic disorders and beyond. Hosted by experts from GeneInCell, this series blends cutting-edge science with real-world impact, offering a deep dive into the future of precision medicine. Tune in to stay ahead in the evolution of human health!Educational content only; not medical advice.

AI's Impact on Biology and Drug Discovery | GeneInCell | 2025

1 hr 10 min

How modern AI is rewiring the life-science stack—from target discovery to first-in-human. This episode unpacks foundation models for proteins/RNAs, generative chemistry, AI-guided ADMET/PK, phenotypic screening on organoids with high-content imaging, multi-omics integration, and self-driving labs with active learning. We compare what’s hype vs. real, walk through validation loops (prospective wet-lab tests, reproducibility, bias control), and map the path to clinic and regulation. Case studies highlight wins and failures—and where AI can truly compress timelines and costs.Educational content only; not medical advice

Spaceflight vs. Your Body- Why Vision Suffers

18 min

This episode spotlights Spaceflight-Associated Neuro-Ocular Syndrome (SANS)—a major risk where microgravity-driven fluid shifts raise eye/brain pressure, leading to optic nerve swelling and vision changes. Beyond SANS, we examine the full spectrum of space eye hazards: corneal abrasions from lunar/planetary dust, chemical burns, infections, and radiation effects. Educational content only; not medical advice.

Microgravity and Human Health: Risks, Benefits, and Spaceflight Hazards

24 min

What does space do to the body—and how can it advance medicine? We break down microgravity’s risks (fluid shifts/SANS, bone loss, muscle atrophy, cardiovascular deconditioning, immune dysregulation, radiation exposure) , then explore benefits for biotech: protein crystallization, stem-cell growth, organoids/tissue engineering, and drug discovery. Clear takeaways for space medicine and Earth health. Educational only; not medical advice.

mRNA Vaccine Research and Therapeutic Applications

17 min

Sources trace mRNA tech from basics to bedside: nucleoside-modified mRNA tames innate sensing and boosts translation; engineering across cap/UTRs/poly(A) plus purification optimizes stability and reduces immune noise. Lipid nanoparticles—especially ionizable lipids—are the enabling delivery system. Beyond infectious-disease vaccines, the field is moving toward on-demand/mobile manufacturing and immune-tolerance applications for autoimmunity/allergy, not just immune activation.

Personalized CRISPR Gene Therapy: A Medical Breakthrough | 2025

25 min

This podcast discusses how CRISPR gene-editing technology is revolutionizing healthcare by making personalized gene therapy a reality. From treating genetic disorders to unlocking precision medicine, CRISPR could transform the way we fight disease.

CRISPR-GPT: AI Automation for Gene-Editing Experiments

21 min

Performing successful CRISPR-Cas9 experiments isn’t just about cutting DNA—it requires precision, programming, and a deep understanding of both the technology and the biology behind it.That’s where CRISPR-GPT comes in: a DNA programming assistant built in Python for automating and optimizing gene-editing experiments.Think of it as your agentic co-pilot in the lab—helping design, analyze, and streamline CRISPR workflows, so you can focus on discovery and innovation.Join us as we explore how AI-driven automation is transforming the way we approach CRISPR, stem cells, and gene editing research.Reference article: https://www.nature.com/articles/s41551-025-01463-z.pdf

CAR T-Cell Therapy: Unleashing Your Body's Army Against Cancer and Beyond

52 min

How reprogrammed T cells become living medicines. In clear, science-first episodes, we trace collection → engineering → infusion, highlight successes in B-cell cancers (CD19, BCMA), unpack risks (CRS, ICANS), and preview what’s next—off-the-shelf/allogeneic CARs, safety switches, and solid-tumor strategies. Subscribe for translational takeaways you can trust.

–

0 ratings from members

5
4
3
2
1

Rate this podcast

Log in to rate and review the shows you listen to.

No reviews yet — be the first member to rate "GeneInCell".

This podcast, its content and its artwork are not owned by, affiliated with, or endorsed by Castquire.

Keep listening

Discover more podcasts like this.

Up next

  1. Nothing queued. Use + Queue on any episode to line it up.

0:00 0:00